Keywords biomarkers targeted therapy triple negative breast cancer introduction breast cancer is well characterized as a heterogeneous disease composed of discrete biologic subtypes which guide clinical management peppercorn et al 2008 . Emerging diagnostic and prognostic biomarkers of triple negative breast cancer therapy 34 unfortunately breast cancer morbidity among cite this article manish g anil k b rama r m emerging diagnostic and prognostic biomarkers of triple negative breast cancer biomed j sci tech res 13 2017 bjstr msid000245. Liquid biopsies and triple negative breast cancer liquid biopsy is emerging as a non invasive alternative to tissue biopsy for monitoring disease progression tumor response to treatment and even to predict prognosis these blood tests have the potential to change the way breast cancer is diagnosed and followed throughout treatment and recovery. Biomarkers to guide treatment for early stage breast cancer july 10 2017 to help doctors provide their patients with the highest quality care the american society of clinical oncology asco recently updated a guideline from 2016 on how to use biomarkers to guide the treatment of early stage breast cancer. Triple negative breast cancer cells rely on glutathione s transferase pi1 and an inhibitor las17 shows encouraging results in a pre clinical study identification and use of biomarkers in treatment strategies for triple negative breast cancer subtypes the journal of pathology 2322 2014 142 150
How it works:
1. Register a Free 1 month Trial Account.
2. Download as many books as you like ( Personal use )
3. No Commitment. Cancel anytime.
4. Join Over 100.000 Happy Readers.
5. That's it. What you waiting for? Sign Up and Get Your Books.